title: Patient-related barriers to fatigue communication in cancer patients receiving active treatment.
abstract: OBJECTIVE
  To explore barriers to reporting fatigue in cancer patients receiving active treatment and the significant factors associated with those barriers from fatigue characteristics (i.e., intensity, duration, and interference with daily life), to demographic characteristics and disease/treatment variables.
  
  
  METHODS
  Patients with various types of cancer (n = 288) were recruited from an outpatient chemotherapy center, and from seven oncology and hematology units in a teaching hospital in northern Taiwan. Data were collected using the Fatigue Management Barriers Questionnaire to explore barriers to fatigue communication.
  
  
  RESULTS
  Fear of distracting the doctor was rated as the highest barrier of reporting fatigue. The degree of fatigue interference with daily life by patients was associated with the willingness to report fatigue. Patients with gastrointestinal cancer experienced more barriers to reporting fatigue than those with hematological cancer. Patients without religion perceived the highest level of barriers to fatigue communication. Outpatients had higher levels of concern than inpatients.
  
  
  CONCLUSIONS
  Discussion with patients about their high level of perceived fatigue barriers before implementing patient education is recommended. Assessing fatigue interference with daily life and identifying factors associated with barriers to reporting fatigue (i.e., type of cancer, religion, and the setting for receiving treatment) are suggested in order to provide better fatigue management in clinical settings.
authors.affiliation: Department of Nursing, College of Medicine, National Taiwan University, Taipei, Taiwan. scshun@ntu.edu.tw
authors.forename: Shiow-Ching
authors.initials: SC
authors.lastname: Shun
authors.forename: Yeur-Hur
authors.initials: YH
authors.lastname: Lai
authors.forename: Fei-Hsiu
authors.initials: FH
authors.lastname: Hsiao
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003144:Communication Barriers; D003430:Cross-Sectional Studies; D005221:Fatigue / Q000209:etiology* / Q000503:physiopathology / Q000523:psychology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications* / Q000628:therapy; D010353:Patient Education as Topic; D010817:Physician-Patient Relations; D011788:Quality of Life; D012307:Risk Factors; D012650:Self Disclosure; D011795:Surveys and Questionnaires
chemical_list: D000970:Antineoplastic Agents